• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

J&J explores takeover bid for Intra-Cellular Therapies, Bloomberg reports

by January 13, 2025
written by January 13, 2025

Investing.com– Johnson & Johnson (NYSE:JNJ) is considering a bid to acquire biopharmaceutical company Intracellular Th (NASDAQ:ITCI), Bloomberg News reported on Sunday, citing sources familiar with the matter.

A deal between both parties could be reached as early as this week, the Bloomberg report stated. Intra-Cellular has a market value of roughly $10 billion.

Intra-Cellular Therapies is best known for Caplyta, its FDA-approved treatment for schizophrenia and bipolar disorders. The potential acquisition could help J&J expand its neuroscience portfolio and offset revenue challenges anticipated from patent expirations on its blockbuster drugs.

The discussions are said to be in an early stage, and no final decision has been made. There is no guarantee that negotiations will lead to a formal deal, according to the sources, according to the report.

Intra-Cellular shares had surged nearly 15% on Friday, reflecting investor anticipation of a potential deal. 

J&J has remained active in pursuing high-growth therapeutic areas, aiming to solidify its pharmaceutical division’s growth amidst intensifying competition.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
US stock futures steady with earnings, inflation in focus
next post
Japan PM asks Biden to allay business community concern over status of Nippon steel-U.S. Steel deal, Jiji says

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Trump implies government could cut contracts and subsidies to Musk’s companies

      June 7, 2025
    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 5, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (505)
    • Stock (6,426)

    Latest News

    • Trump implies government could cut contracts and subsidies to Musk’s companies
    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring

    Popular News

    • Argentina’s beleaguered economy set to rebound in 2025: Reuters poll
    • Chinese stocks to face pressure from tariffs, limited stimulus, UBS Says

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy